Navigation Links
Maxim Peptide Celebrates Second Anniversary Online with an Updated Website and Special Deals Section
Date:7/12/2014

West Palm Beach, FL (PRWEB) July 12, 2014

Maxim Peptide, a website that features a wide variety of high-quality peptides that are used solely in scientific experiments, is currently celebrating its second anniversary online. To honor two successful years in business, Maxim Peptide, which was created by the founders of JNS Performance LLC, has just launched a new and updated website that now features a special deals section. In addition, the research blog section has been updated with fascinating articles about peptide research, including a new series on antibodies.

For researchers who are looking for top-quality peptides for their experiments, the founders of Maxim Peptide pride themselves on offering the best possible products.

As an article on the Maxim Peptide website explains, peptides are used in a research setting in a variety of ways. For example, peptides can be designed to interact with certain tissues or cells, and are then given the chance to bond or break. Researchers will use this data to determine the biological process that is completed, as well as the success of the function.

“The ability to create peptides with sound bonds is essential both to natural peptides formed by the body and synthetic peptides that are applied to animals for research purposes,” the article explained, add that the sooner a chemical bond within a peptide is broken, the shorter the effective life of the peptide will be.

One of Maxim Peptide’s most popular peptide research products is called IGF-1 LR3. Researchers worldwide have used this peptide from Maxim Peptide and have found it to perform exceptionally well in the lab. It is often used in scientific research on liver secretions in animals, and the peptide has also been linked to other theoretical benefits in research settings, including increased endurance and muscle retention.

Anybody who would like to learn more about Maxim Peptide is welcome to visit the newly redesigned website; there, they can read the newly-posted educational articles as well as shop for top-quality peptides.

About Maxim Peptide and JNS Performance LLC:

JNS Performance LLC was launched so that the founders of the company can provide their customers with the best products available for their research. The founders understand the importance of having a high quality product in order to receive the best results, and that is exactly why they are here. They can confidently say that their serums, which are available at the Maxim Peptide website, are of the highest quality and will give their customers the ability to properly conduct their research. They believe the products will speak for themselves, but they also make a commitment to always provide everybody with great customer service. For more information, please visit http://www.maximpeptide.com/.

Read the full story at http://www.prweb.com/releases/Maxim-Peptide/top-quality-peptides/prweb12011875.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. Leading Population Health Management Solutions Provider Offers Tips and Tricks to Maximize the Planned Visit
2. Grudi Associates Offers Businesses a New Way to Maximize Their Telecom & IT ROI through Innovative Outsourced Telecom Management and Telecom Service Optimization
3. Memory Supplements
4. Power Memory Formula Reviews Can Help People Maximize and Optimize Their Memorizing Power - abb2u.com
5. New Muscle Maximizer Review From ReviewedToday.org Looks at Secrets Behind Product's Success
6. AlignLife Celebrates National Detox Day with a New Year, New You Workshop to Maximize Educational Reach
7. “High Performance” Helps People Maximize Their Training Results” - abb2u.com
8. Upcoming AIS Virtual Conference to Provide Guidance on Maximizing Medicare Star Ratings
9. Entry Software’s TeamHeadquarters, v. 7, Integrates ITSM and Project Management to Maximize Business Value from IT
10. Liquid Vitamin Company, drEames Maximum Life Launches New Website
11. TheBeautyPlace.com Reveals How to Get Maximum Savings This Short Holiday Season
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2017)... ... February 26, 2017 , ... IndustryArchive.Org . is announcing ... B2B Marketing. B2B Sellers will now only pay for B.A.N.T. quality sales leads based ... of IndustryArchive.Org, said, “Given the new reality that B2B buyers are controlling the sales ...
(Date:2/25/2017)... ... February 25, 2017 , ... FCPX users now have ... from Pixel Film Studios. With ProSharpen Color users have total control over sharpening amount, ... their color range. With color spectrum tools users can visually see the color range ...
(Date:2/24/2017)... ... February 24, 2017 , ... An in-depth computational analysis of ... of Pittsburgh points to eight genes that may explain why susceptibility to one of ... results of a study published today in the journal npj Schizophrenia. , “There ...
(Date:2/24/2017)... ... February 24, 2017 , ... Healthcare Associates of ... Center at Craig Ranch building at 8080 State Highway 121, Suite 210, McKinney, Texas ... easy access to Highway 121. , As the practice has grown, the need for ...
(Date:2/24/2017)... ... 2017 , ... The International Association of Eating Disorders Professionals (iaedp) announces the ... body image mannequin art competition. Selected from 15 submissions from around the nation, the ... the 31st annual iaedp Symposium, March 22 – 26 in Las Vegas. , This ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... , Australie, le 24 février 2017 ITL Limited, ... santé diversifiée innovante, est ravie d,annoncer les excellents résultats ... la période précédente correspondante. Une présentation complète « Résultats et ... être consultée ici . Faits ... de 2,12 millions $ (Déc. 2015 : 1,04 million $ ; en hausse de ...
(Date:2/24/2017)... , Feb. 23, 2017 ... insights on the various drugs being developed ... covers all the drugs that are in ... Clinical). The pipeline focuses on novel pharmacologic ... antibodies, stem cell therapies, recombinant proteins and ...
(Date:2/24/2017)... Feb. 24, 2017  Xynomic Pharmaceuticals, Inc., an oncology ... it has acquired exclusive worldwide rights to develop, ... HDAC inhibitor targeting hematological and solid tumors. ... 1 and 2 clinical trials of Abexinostat in ... have already been completed, demonstrating that Abexinostat is ...
Breaking Medicine Technology: